Niamh Madigan | 02/22/2013
Gert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade, including:
The establishment of harmonised guidelines
The Formation of the EMA
The recent document published by the FDA, which is a significant step in dealing with advanced formulations
He also looks to the future growth of generics and the effects QbD and PAT will have on that market.
Have Your Sa...
To continue reading this story Click Here
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More